Fluvastatin Sensitizes Pancreatic Cancer Cells toward Radiation Therapy and Suppresses Radiation- and/or TGF-β-Induced Tumor-Associated Fibrosis

Investigators evaluated the radiosensitizing and anti-RIF potential of fluvastatin in pancreatic cancer (PC). Short-term viability and clonogenic survival assays were used to evaluate the radiosensitizing potential of fluvastatin in multiple human and murine PC cell lines.